|
Prescribe IV iron in pregnancy (n = 444)
|
|
Yes
|
426
|
95.9
|
|
No
|
18
|
4.1
|
|
Prescribe IV iron postpartum (n = 429)
|
|
Yes
|
364
|
84.8
|
|
No
|
65
|
15.2
|
|
Location of IV iron administration (n = 421)
|
|
Hospital
|
386
|
91.7
|
|
Non-hospital
|
4
|
1.0
|
|
Both
|
31
|
7.4
|
|
Number of infusions prescribed in pregnancy and/or postpartum per annum (n = 425)
|
|
< 10
|
132
|
31.1
|
|
10–19
|
107
|
25.2
|
|
20–29
|
80
|
18.8
|
|
30 or more
|
97
|
22.8
|
|
Don’t prescribe
|
9
|
2.1
|
|
IV preparation prescribed (n = 425)a
|
|
Ferric carboxymaltose (Ferinject)
|
381
|
89.6
|
|
Iron polymaltose (Ferrosig, Ferrum-H)
|
54
|
12.7
|
|
Don’t know
|
16
|
3.8
|
|
Iron sucrose (Venofer)
|
11
|
2.6
|
|
Othera
|
7
|
1.6
|
|
Gestation range of IV iron prescribing in IDAP (n = 419)b
|
|
Prescribe during pregnancy
|
410
|
97.9
|
|
< 13 weeks
|
35
|
8.4
|
|
13–27 weeks
|
145
|
34.6
|
|
≥ 28 weeks
|
406
|
96.9
|
|
Do not prescribe in pregnancy
|
9
|
2.1
|
|
Gestation range of IV iron prescribing in pregnancy for ID without anaemia (n = 413)7
|
|
Prescribe during pregnancy
|
220
|
53.3
|
|
< 13 weeks
|
14
|
3.4
|
|
13–27 weeks
|
51
|
12.3
|
|
≥ 28 weeks
|
220
|
53.3
|
|
Do not prescribe
|
193
|
46.7
|
